Asset Details
Do you wish to reserve the book?
Determinants of HPV vaccine uptake among female junior secondary school students in Uyo, Nigeria
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Determinants of HPV vaccine uptake among female junior secondary school students in Uyo, Nigeria
Do you wish to request the book?
Determinants of HPV vaccine uptake among female junior secondary school students in Uyo, Nigeria
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Determinants of HPV vaccine uptake among female junior secondary school students in Uyo, Nigeria
2025
Overview
Background
Human Papillomavirus (HPV) is the main cause of cervical cancer, particularly in low- and middle-income countries, yet vaccine uptake remains suboptimal. This study assessed the determinants of HPV vaccine uptake among female junior secondary students in Uyo, Akwa Ibom State, Nigeria.
Methods
A cross-sectional study was conducted among 400 students from May to July 2024 using multi-stage sampling and structured interviewer-administered questionnaires to gather sociodemographic data and evaluate HPV vaccine knowledge, attitudes, and uptake, including barriers to vaccination. Analysis involved descriptive statistics, chi-square tests, and logistic regression using GraphPad Prism 9, with significance at
p ≤
0.05.
Results
The study revealed that 37.3% had poor HPV knowledge, 51.3% had fair knowledge, and 11.5% had good knowledge. Although 90% exhibited positive attitudes, only 36.3% had received at least one vaccine dose, and just 5.5% completed the vaccination series. Determinants of HPV vaccine uptake included being a preadolescent at age 9 (aOR = 4.16, 95% CI 1.86–9.57,
p =
0.0006), early adolescence at 10–13 years (aOR = 3.01, 1.66–5.70,
p =
0.0004), being in JSS1 (aOR = 2.28, 1.14–4.77,
p =
0.0231), or JSS2 (aOR = 3.39, 1.62–7.38,
p =
0.0015) while students from the Anang ethnic group were significantly less likely to be vaccinated (aOR = 0.15, 0.04–0.49,
p =
0.0032). Barriers included limited awareness, logistical challenges, and safety concerns.
Conclusions
Despite favourable attitudes, HPV vaccine uptake and completion among students were low, highlighting urgent needs for targeted interventions and improved vaccine accessibility.
